Aerosol Delivery Efficiency With High-Flow Nasal Cannula Therapy in Neonatal, Pediatric, and Adult Nasal Upper-Airway and Lung Models.

Robert M DiBlasiRebecca J EngbergJonathan PoliKristen E CarlinNiko KontoudiosP Worth LongestMasaki Kajimoto

Published in: Respiratory care (2024)

The inhaled lung dose was low (1-5%) during HFNC. Approaches that streamline aerosol delivery are needed to provide safe and effective therapy to patients receiving aerosolized medications with this HFNC system.

Keyphrases

chronic rhinosinusitis
extracorporeal membrane oxygenation
obstructive sleep apnea
young adults
intensive care unit
respiratory failure
acute respiratory distress syndrome
childhood cancer
positive airway pressure
mechanical ventilation